Explore

Trendline Trendline
Frozen Pasta Startup Ripi Secures $2.4 Million to Expand Market Presence

Frozen Pasta Startup Ripi Secures $2.4 Million to Expand Market Presence

Frozen Pasta Startup Ripi Secures $2.4 Million to Expand Market Presence
Trendline Trendline
AI Investor Elad Gil Discusses Strategic Exit Timing for Startups

AI Investor Elad Gil Discusses Strategic Exit Timing for Startups

AI Investor Elad Gil Discusses Strategic Exit Timing for Startups
Trendline Trendline
ViewsML Secures $4.9M Funding to Advance AI-Driven Biomarker Staining

ViewsML Secures $4.9M Funding to Advance AI-Driven Biomarker Staining

ViewsML Secures $4.9M Funding to Advance AI-Driven Biomarker Staining
Trendline Trendline
AI Investors Highlight Critical 12-Month Window for Business Exits

AI Investors Highlight Critical 12-Month Window for Business Exits

AI Investors Highlight Critical 12-Month Window for Business Exits
Trendline Trendline
AI Startup Cursor Seeks $2 Billion Funding, Valuation Surpasses $50 Billion

AI Startup Cursor Seeks $2 Billion Funding, Valuation Surpasses $50 Billion

AI Startup Cursor Seeks $2 Billion Funding, Valuation Surpasses $50 Billion
Trendline Trendline
AI Investors Discuss Timing for Optimal Business Exits Amid Market Fluctuations

AI Investors Discuss Timing for Optimal Business Exits Amid Market Fluctuations

AI Investors Discuss Timing for Optimal Business Exits Amid Market Fluctuations
Trendline Trendline
Pillsbury Expands Venture Capital Practice with New Partner Duo from McDermott

Pillsbury Expands Venture Capital Practice with New Partner Duo from McDermott

Pillsbury Expands Venture Capital Practice with New Partner Duo from McDermott
Trendline Trendline
ViewsML Secures $4.9M to Advance AI-Driven Virtual Biomarker Staining Platform

ViewsML Secures $4.9M to Advance AI-Driven Virtual Biomarker Staining Platform

ViewsML Secures $4.9M to Advance AI-Driven Virtual Biomarker Staining Platform
Trendline Trendline
Venture Capitalist Ron Conway Begins Treatment for Rare Cancer, Steps Back from SV Angel

Venture Capitalist Ron Conway Begins Treatment for Rare Cancer, Steps Back from SV Angel

Venture Capitalist Ron Conway Begins Treatment for Rare Cancer, Steps Back from SV Angel
Trendline Trendline
AI Startup Cursor in Talks to Raise $2 Billion at $50 Billion Valuation Amid Growth

AI Startup Cursor in Talks to Raise $2 Billion at $50 Billion Valuation Amid Growth

AI Startup Cursor in Talks to Raise $2 Billion at $50 Billion Valuation Amid Growth
Trendline Trendline
Venture Capitalist Ron Conway Announces Cancer Diagnosis and Treatment Plan

Venture Capitalist Ron Conway Announces Cancer Diagnosis and Treatment Plan

Venture Capitalist Ron Conway Announces Cancer Diagnosis and Treatment Plan
Trendline Trendline
AI Startup Cursor Seeks $2 Billion Funding at $50 Billion Valuation Amid Rapid Growth

AI Startup Cursor Seeks $2 Billion Funding at $50 Billion Valuation Amid Rapid Growth

AI Startup Cursor Seeks $2 Billion Funding at $50 Billion Valuation Amid Rapid Growth